2022
DOI: 10.22141/2224-0721.18.4.2022.1177
|View full text |Cite
|
Sign up to set email alerts
|

Product of metabolic activity of intestinal microbium trimethylamine-N-oxide (TMAO) — biomarker of progression of atherosclerosis-copy in the heart of the heart

Abstract: The literature data on the importance of intestinal microbiota as an endocrine organ — producer of biologically active metabolites, which perform key functions to maintain metabolic homeostasis of the whole organism, in particular the condition of the cardiovascular system, are analyzed. Clinical and experimental studies using a metabolomical approach have shown that the development of atherosclerotic CVD is often associated with ele­vated levels of one of the microbial metabolites, trimethylamine N-oxide (TMA… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 67 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?